ATG16L2 and systemic lupus erythematosus: One study found that increased expression of autophagy-related proteins ATG5 and ATG16L2 promotes the development of SLE, suggesting that targeting and reducing the expression of ATG5 and ATG16L2 can treat SLE (107).